Anti-(human Cd Antigen Cd37) (synthetic Human-mus Musculus Fragment Tru-016) Uses, Dosage, Side Effects and more

Anti-(human Cd Antigen Cd37) (synthetic Human-mus Musculus Fragment Tru-016) is under investigation in clinical trial NCT01188681 (Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia).

Attribute	Details
Trade Name	Anti-(human Cd Antigen Cd37) (synthetic Human-mus Musculus Fragment Tru-016)
Generic	Otlertuzumab
Otlertuzumab Other Names	Immunoglobulin, anti-(human cd antigen cd37) (synthetic human-mus musculus fragment tru-016), dimer, Otlertuzumab
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph